Literature DB >> 10608951

Necessity of complete intake of phenylalanine-free amino acid mixture for metabolic control of phenylketonuria.

G P Duran1, F J Rohr, A Slonim, F Güttler, H L Levy.   

Abstract

The importance of complete or almost complete intake of the recommended amount of phenylalanine-free amino acid mixture (AAM) for control of blood phenylalanine level in patients being treated for phenylketonuria (PKU) has not been universally appreciated. We observed the effect of complete intake of AAM on plasma phenylalanine levels during hospitalization in 6 patients with PKU (5 pregnant women with PKU and 1 child) who had poor metabolic control because of less than full compliance with prescribed AAM intake. Before hospitalization, all but 1 of the patients had blood phenylalanine levels above 1,000 mumol/L; in 1 patient the blood phenylalanine level was 703 mumol/L. During 9 periods of observation in the 6 patients, the levels of plasma phenylalanine decreased to the recommended range of below 360 mumol/L within 2 to 6 days of hospitalization. These experiences indicate a close relationship between compliance with prescribed AAM intake and control of blood phenylalanine level. We propose that hospitalization be considered when patients with PKU who are consuming a phenylalanine-restricted diet fail to maintain blood phenylalanine levels in the targeted range despite reported compliance with the prescribed intake of dietary phenylalanine and AAM.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10608951     DOI: 10.1016/S0002-8223(99)00382-X

Source DB:  PubMed          Journal:  J Am Diet Assoc        ISSN: 0002-8223


  8 in total

1.  Acceptability of a new modular protein substitute for the dietary treatment of phenylketonuria.

Authors:  F J Rohr; A W Munier; H L Levy
Journal:  J Inherit Metab Dis       Date:  2001-11       Impact factor: 4.982

2.  Protein substitute dosage in PKU: how much do young patients need?

Authors:  A MacDonald; A Chakrapani; C Hendriksz; A Daly; P Davies; D Asplin; K Hall; I W Booth
Journal:  Arch Dis Child       Date:  2006-03-17       Impact factor: 3.791

3.  Acceptable low-phenylalanine foods and beverages can be made with glycomacropeptide from cheese whey for individuals with PKU.

Authors:  Kyungwha Lim; Sandra C van Calcar; Kathryn L Nelson; Sally T Gleason; Denise M Ney
Journal:  Mol Genet Metab       Date:  2007-07-23       Impact factor: 4.797

Review 4.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

5.  Exploring Drivers of Liking of Low-Phenylalanine Products in Subjects with Phenyilketonuria Using Check-All-That-Apply Method.

Authors:  Cristina Proserpio; Ella Pagliarini; Juri Zuvadelli; Sabrina Paci; Alice Re Dionigi; Giuseppe Banderali; Camilla Cattaneo; Elvira Verduci
Journal:  Nutrients       Date:  2018-08-28       Impact factor: 5.717

6.  Low increase in phenylalanine tolerance during pregnancies in PKU woman with high prepregnancy BMI and postconceptional initiation of diet: A case report.

Authors:  Joanna Żółkowska; Kamil Hozyasz
Journal:  Int J Reprod Biomed       Date:  2019-11-07

Review 7.  Protein Substitutes in PKU; Their Historical Evolution.

Authors:  Anne Daly; Sharon Evans; Alex Pinto; Catherine Ashmore; Anita MacDonald
Journal:  Nutrients       Date:  2021-02-02       Impact factor: 5.717

8.  An Observational Study Evaluating the Introduction of a Prolonged-Release Protein Substitute to the Dietary Management of Children with Phenylketonuria.

Authors:  Anita MacDonald; Catherine Ashmore; Anne Daly; Alex Pinto; Sharon Evans
Journal:  Nutrients       Date:  2020-09-03       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.